EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Intracellular copper redox modulation disrupts ROS–Ca²⁺ amplification in an ATP7B-deficient zebrafish model of Wilson’s disease

Itzchak Angel, Kalaichitra Periyasamy, Micha Gladnikoff, Benin Joseph, Raphael Mayer, Erez Aminov

Advances in Redox Research · 2026-06 · 19 · 100168

DOI: 10.1016/j.arres.2026.100168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Redox Research, 2026-06. Verfasst von Itzchak Angel und 5 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excess labile copper catalyzes Fenton-type redox cycling, amplifying reactive oxygen species (ROS) and disrupting mitochondrial and calcium homeostasis. In Wilson’s disease (WD), ATP7B deficiency leads to hepatic copper accumulation and progressive redox-driven tissue injury. Here, we investigated whether intracellular copper modulation interrupts ROS–Ca²⁺ amplification cascades and restores cellular, functional and organ-level homeostasis. Copper challenge in human epithelial, fibroblast, and proliferative cell lines induced dose-dependent ROS accumulation, delayed intracellular Ca²⁺ transients, and suppression of metabolic activity. Pre-treatment with Telomir-Zn (0.1–5 µM) significantly reduced DCFH-DA ROS signals following Cu²⁺ or H₂O₂ exposure, attenuated Fluo-8–detected Ca²⁺ flux amplitude and preserved mitochondrial-associated metabolic viability. These effects were observed across cell types, consistent with modulation of labile redox-active copper pools. In ATP7B^C271X zebrafish, oral Telomir-Zn (1.5–5 ng) reduced hepatic copper levels, improved locomotor performance, normalized AST, ALT and bilirubin, attenuated hepatorenal degeneration, and significant survival in a dose-dependent manner. Histological analyses demonstrated reduced necrosis and inflammatory infiltration relative to untreated mutants. Collectively, these findings demonstrate that intracellular copper redox modulation disrupts ROS–Ca²⁺ feedback amplification and mitigates mitochondrial-associated injury in ATP7B deficiency. Targeting labile copper-driven redox cascades may represent a mechanistically distinct strategy for restoring tissue homeostasis in copper-overload disorders.

Zitieren

APA

Angel, I., Periyasamy, K., Gladnikoff, M., Joseph, B., Mayer, R., & Aminov, E. (2026). Intracellular copper redox modulation disrupts ROS–Ca²⁺ amplification in an ATP7B-deficient zebrafish model of Wilson’s disease. Advances in Redox Research, 19, 100168. https://doi.org/10.1016/j.arres.2026.100168

Vancouver

Angel I, Periyasamy K, Gladnikoff M, Joseph B, Mayer R, Aminov E. Intracellular copper redox modulation disrupts ROS–Ca²⁺ amplification in an ATP7B-deficient zebrafish model of Wilson’s disease. Advances in Redox Research. 2026;19:100168. doi:10.1016/j.arres.2026.100168

BibTeX
@article{Angel2026,
  author = {Angel, Itzchak and Periyasamy, Kalaichitra and Gladnikoff, Micha and Joseph, Benin and Mayer, Raphael and Aminov, Erez},
  title = {Intracellular copper redox modulation disrupts ROS–Ca²⁺ amplification in an ATP7B-deficient zebrafish model of Wilson’s disease},
  journal = {Advances in Redox Research},
  year = {2026},
  volume = {19},
  pages = {100168},
  doi = {10.1016/j.arres.2026.100168}
}
Kostenlos starten →